PS

Pierre-Henri Storck

VI Vertex Pharmaceuticals Incorporated: 5 patents #7 of 186Top 4%
Johnson & Johnson: 3 patents #190 of 1,079Top 20%
Overall (2017): #10,877 of 506,227Top 3%
8
Patents 2017

Issued Patents 2017

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
9718827 Compounds useful as inhibitors of ATR kinase Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Christopher John Davis, Rebecca Davis +14 more 2017-08-01
9688691 Macrocyclic quinazole derivatives and their use as MTKI Eddy Jean Edgard Freyne, Marc Willems, Peter Ten Holte, Alexandra Papanikos, Werner Constant Johan Embrechts +1 more 2017-06-27
9670215 Compounds useful as inhibitors of ATR kinase Nadia Ahmad, Jean-Damien Charrier, Chris Davis, Gorka Etxebarria I Jardi, Damien Fraysse +5 more 2017-06-06
9663519 Compounds useful as inhibitors of ATR kinase Jean-Damien Charrier, Chris Davis, Steven Durrant, Gorka Etxebarria I Jardi, Damien Fraysse +4 more 2017-05-30
9650381 Compounds useful as inhibitors of ATR kinase Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more 2017-05-16
9630956 Compounds useful as inhibitors of ATR kinase Jean-Damien Charrier, Hayley Binch, Dennis James Hurley, Thomas Cleveland, Pramod Joshi +10 more 2017-04-25
9598396 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors Patrick René Angibaud, Laurence Anne Mevellec, Bruno Roux, Christophe Meyer, Jorge Eduardo Vialard 2017-03-21
9573933 Inhibitors of the interaction between MDM2 and P53 Virginie Sophie Poncelet, Sophie Coupa, Bruno Schoentjes 2017-02-21